| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 04/27/2005 | EP1525209A2 1'-, 2'- and 3' -modified nucleoside derivatives for treating flaviviridae infections |
| 04/27/2005 | EP1455799B1 Pharmaceutical combinations of adenosine a-2a and beta-2-adrenergic receptor agonists |
| 04/27/2005 | EP1143974B1 Pharmaceutical compositions for alleviating discomfort |
| 04/27/2005 | EP0948514B1 Method for the synthesis of nucleotide or oligonucleotide phosphoramidites |
| 04/27/2005 | CN1610546A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
| 04/26/2005 | US6884882 Introducing an acetylene group at the 5-position of 2'-deoxyuridine, and reacting the formed intermediate 2'-deoxyuridine having the acetylene group at the 5-position, with a benzyl azide derivative |
| 04/26/2005 | US6884881 Reacting a neucleoside containing a leaving group with trialkoxyaluminum compound |
| 04/26/2005 | US6884880 Suspending adenine in N-methylimidazole, stirring under nitrogen atmosphere while adding heptanoic anhydride, heating, the cooling to crystallize; avoids formation of geometrical isomers |
| 04/26/2005 | US6884584 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders |
| 04/21/2005 | WO2005035545A2 Single nucleotide polymorphism analysis of highly polymorphic target sequences |
| 04/21/2005 | WO2005034943A1 Indole antiviral compositions and methods |
| 04/21/2005 | WO2005021568A3 Novel tricyclic nucleosides or nucleotides as therapeutic agents |
| 04/21/2005 | WO2005012327A3 Nucleotide phosphoramidates as anticancer agents |
| 04/21/2005 | WO2004096824A3 Nucleoside derivative, modified oligonucleotide, method for their synthesis and applications thereof |
| 04/21/2005 | WO2004041203A3 Gemcitabine prodrugs, pharmaceutical compositions and uses thereof |
| 04/21/2005 | WO2002057425A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 04/21/2005 | US20050085439 Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof |
| 04/21/2005 | US20050085437 Crystalline drug form |
| 04/21/2005 | US20050084898 Comparative fluorescence hybridization to nucleic acid arrays |
| 04/21/2005 | CA2540551A1 Single nucleotide polymorphism analysis of highly polymorphic target sequences |
| 04/20/2005 | EP1523489A2 Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 04/20/2005 | EP1523380A2 Multiple layer membrane and method for fabrication thereof |
| 04/20/2005 | CN1608076A Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines |
| 04/20/2005 | CN1608075A Avermectin b1 derivatives having an aminosulfonyloxy substitutent in the 4''-position |
| 04/20/2005 | CN1606983A Beta-L-2'deoxy-nucleosides for the treatment of hepatitis B |
| 04/20/2005 | CN1197871C 5'-deoxy-cytidine derivatives |
| 04/19/2005 | US6881837 Generation of s-adenosyl-L-methionine; generate s-adenosyl-l-methionine, methylate, recover s-adenosyl-l-methionine |
| 04/19/2005 | US6881836 Blocking; high density arrays; activation |
| 04/19/2005 | US6881725 Administering to a subject a purine derivative to reduce traumatic pain, neuropathic pain, organ pain and pain associated with diseases |
| 04/19/2005 | CA2362777C Desulfurizing agent and method for desulfurization of hydrocarbon |
| 04/14/2005 | WO2005033121A2 Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs |
| 04/14/2005 | WO2004096197A8 5-aza-7-deazapurine nucleosides for treating flaviviridae |
| 04/14/2005 | US20050080252 Process for preparing antiviral nucleoside derivatives |
| 04/14/2005 | US20050080050 Lipid analogs for treating viral infections |
| 04/14/2005 | US20050079529 Using laser excitation and fluorescence to identify regions of hybridization along microarray comprised of immobilized polynucleotides; gene expression analysis; genomics |
| 04/14/2005 | US20050079225 Methods and therapeutic compositions in the treatment of advanced cancer |
| 04/13/2005 | EP1015469B1 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues |
| 04/13/2005 | CN1196710C Production of 5'-guanylate disodium. 5'-inosine disodium mixed crystals |
| 04/13/2005 | CN1196704C Process for preparing inhibitors of nucleoside metabolism |
| 04/07/2005 | WO2005030997A1 Methods and device for dna sequencing using surface enhanced raman scattering (sers) |
| 04/07/2005 | WO2005009418A3 Purine nucleoside analogues for treating diseases caused by flaviviridae including hepatitis c |
| 04/07/2005 | WO2004002422A3 2’-c-methyl-3’-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| 04/07/2005 | US20050075491 Conjugating oligonucleotide with 3-substituted pyrazolo(3,4-d)pyrimidines and/or 5-substituted pyrimidine minor groove binder |
| 04/07/2005 | US20050075309 Purine nucleoside analogues for treating Flaviviridae including hepatitis C |
| 04/07/2005 | US20050075308 Methods and compositions for producing antigenic responses |
| 04/07/2005 | US20050074857 Method for producing a pyrimidine nucleoside compound and a new pyrimidine nucleoside compound |
| 04/07/2005 | US20050074771 For attachment to steroids, reporter molecules, reporter enzymes, lipophilic molecules, peptides or proteins; for detecting RNA in samples |
| 04/07/2005 | US20050074760 Enzymatic nucleic acids containing 5'-and/or 3'-cap structures |
| 04/07/2005 | US20050074748 Bioreactive agents |
| 04/06/2005 | CN1195772C Nb heterocyclic 8-modified adenosine derivs. |
| 04/06/2005 | CN1195771C Method for purifying 5'-protection Thymidine and novel derivant |
| 04/06/2005 | CN1195770C Preparation of d4T from 5-methyl uridine |
| 04/06/2005 | CN1195769C Natural antitumor or antiviral substances and use of the same |
| 04/06/2005 | CN1195768C 3'-substd. nucleoside derivs. |
| 04/05/2005 | US6875860 Method for purifying 5′ -protected thymidines and novel derivatives thereof |
| 04/05/2005 | US6875859 Heterocyclic compounds and their use in the detection of nucleic acids |
| 04/05/2005 | US6875752 Therapy for grampositive bacteria; bactericides |
| 04/05/2005 | US6875751 3′-prodrugs of 2′-deoxy-β-L-nucleosides |
| 04/05/2005 | US6875750 Methylation of target compound using methyltransferase |
| 04/05/2005 | US6875593 Oligomers capable of forming triplexes with various target sequences such as virus or oncogene sequences by coupling into major groove of target DNA duplex or forming duplexes by binding to single-stranded DNA or RNA encoded by target genes |
| 04/05/2005 | US6875451 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 03/31/2005 | WO2005028494A1 Process for producing 5'-phosphitylated monomer and h-phosphonate oligonucleotide derivative |
| 03/31/2005 | WO2005028489A2 Novel adenosine a3 receptor agonists |
| 03/31/2005 | WO2005028481A2 Fused pentacyclic polyethers |
| 03/31/2005 | WO2005027838A2 Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives |
| 03/31/2005 | WO2004104213A3 Nucleic acids and polypeptides of c1 bacteriophage and uses thereof |
| 03/31/2005 | WO2004083155A3 Nucleotide lipid ester derivatives |
| 03/31/2005 | WO2004072234A3 Protection of nucleosides |
| 03/31/2005 | WO2004052899A3 Process for the production of 2'-branched nucleosides |
| 03/31/2005 | US20050070708 May be used for the analysis of nucleic acid sequences by incorporating these derivatives into nucleic acid chains, and also the enzymatic labelling and immobilization or detection of sequences |
| 03/31/2005 | US20050070556 Having immunomodulatory activity; for therapy and prophylaxis of infections caused by adenovirus, cytomegalovirus, hepatitis A virus (HAV), hepatitis B virus (HBV), flaviviruses including Yellow Fever virus, herpes virus |
| 03/31/2005 | US20050069495 For therapy of malignant tumor |
| 03/31/2005 | CA2539588A1 Fused pentacyclic polyethers |
| 03/31/2005 | CA2538857A1 Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives |
| 03/31/2005 | CA2537094A1 Novel adenosine a3 receptor agonists |
| 03/30/2005 | EP1517993A2 Selective functionalization of hydrocarbons with isolated oxygenases and mediator-based regeneration |
| 03/30/2005 | EP1389909A4 Antimicrobial compounds and methods for their use |
| 03/30/2005 | EP1237898B1 N?6 heterocyclic 8-modified adenosine derivatives |
| 03/30/2005 | EP0791056B1 Lipid-cleavage enzyme complex |
| 03/30/2005 | CN1194984C Antibiotic and its prepn and application |
| 03/29/2005 | US6872809 Nucleoside derivatives |
| 03/24/2005 | WO2005026318A2 Methods and compositions for producing antigenic responses |
| 03/24/2005 | WO2005026188A1 Metal complex type nucleic acid |
| 03/24/2005 | WO2005026187A1 Nucleoside or nucleotide having nonnatural base and use thereof |
| 03/24/2005 | WO2005026186A1 Β-l-nucleosides and use thereof as pharmaceutical agents for treating viral diseases |
| 03/24/2005 | WO2005026184A2 Synthesis and compositions of 2'-terminator nucleotides |
| 03/24/2005 | WO2004104017A3 Methods for preparing 2-alkynyladenosine derivatives |
| 03/24/2005 | WO2004088312A3 Fluorescently tagged ligands |
| 03/24/2005 | WO2004086949A3 Dna markers for management of cancer |
| 03/24/2005 | WO2004074503A3 Nucleic acid sequencing methods, kits and reagents |
| 03/24/2005 | US20050065110 Synergistic mixture; antioxidant; cardiovascular disorders; antidiabetic agents |
| 03/24/2005 | US20050065108 Antidiabetic agents; antilipemic agents |
| 03/24/2005 | US20050064478 Universal nucleic acid amplification system for nucleic acids in a sample |
| 03/24/2005 | US20050064468 concentration, removing or separation of nucleotide bases or nucleotide sequences containing bases from solid supports |
| 03/24/2005 | US20050064463 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders |
| 03/24/2005 | CA2538434A1 Novel indolopyrrolocarbazole derivative with antitumor activity |
| 03/24/2005 | CA2533926A1 Methods and compositions for producing antigenic responses |
| 03/23/2005 | EP1515970A1 Alkynylpurine compounds and production methods thereof |
| 03/23/2005 | CN1599745A Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist |
| 03/23/2005 | CN1599744A Beta -2'-or 3'-halonucleosides |